🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is to compare the risk/benefit profile over six-month follow-up ...
Status
Active Not Recruiting
Location
ASST HPG23 - Unità di Nefrologia
Start Date
2024-07-30
Trial ID
NCT06374095
Treatments Being Tested
Infants with severe combined immunodeficiency (SCID) have a profound decrea...
Status
Active Not Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2021-09-02
Trial ID
NCT03597594
Recent advances in allogeneic hematopoietic cell transplantation (allo-SCT)...
Status
Completed
Location
Besançon University Hospital
Start Date
2012-03-02
Trial ID
NCT01566656
Treatments Being Tested
Primary Objective: To investigate the efficacy of the standard dose of Thy...
Status
Completed
Location
CHINA
Start Date
2017-08-16
Trial ID
NCT03099122
The primary objective is to evaluate a NULOJIX® (belatacept) based regimens...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-07
Trial ID
NCT01856257
Rabbit antithymocyte globulin (rATG) is approved for the treatment of acute...
Status
Unknown
Location
Houston Methodist Hospital
Start Date
2014-03
Trial ID
NCT02102854
Treatments Being Tested
This research study is to determine if donor blood stem cells given after l...
Status
Unknown
Location
Stanford University Medical Center
Start Date
2017-02-14
Trial ID
NCT03292445
Treatments Being Tested
The goal of this clinical research study is to learn if it is safe and feas...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-07-13
Trial ID
NCT01471067
The primary goal of the study is to determine the incidence and severity of...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2010-11
Trial ID
NCT01246206
Treatments Being Tested
The investigators expect to better characterise B cell subpopulation and fu...
Status
Completed
Location
CHU Brest
Start Date
2015-02-09
Trial ID
NCT02894606
Treatments Being Tested